# Willem A. Bax

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/willem-a-bax/

## Facts

| Field | Value |
| --- | --- |
| Citations | 5,635 |
| Field | Nitric Oxide and Endothelin Effects |
| h-index | 28 |
| i10-index | 54 |
| Last Known Institution | Çevre, Şehircilik ve İklim Değişikliği Bakanlığı |
| OpenAlex ID | https://openalex.org/A5077576138 |
| ORCID iD | 0000-0002-2177-1475 |
| Works | 86 |

## Researcher papers

- [Colchicine in Patients with Chronic Coronary Disease](https://scholariq.org/papers/colchicine-in-patients-with-chronic-coronary-disease/)
- [Angiotensin-Converting Enzyme in the Human Heart](https://scholariq.org/papers/angiotensin-converting-enzyme-in-the-human-heart/)
- [Coronary Side-Effect Potential of Current and Prospective Antimigraine Drugs](https://scholariq.org/papers/coronary-side-effect-potential-of-current-and-prospective-antimigraine-drugs/)
- [Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS](https://scholariq.org/papers/effect-of-sitagliptin-on-kidney-function-and-respective-cardiovascular-outcomes/)
- [Prorenin, Renin, Angiotensinogen, and Angiotensin-Converting Enzyme in Normal and Failing Human Hearts](https://scholariq.org/papers/prorenin-renin-angiotensinogen-and-angiotensin-converting-enzyme-in-normal-and/)
- [The current endothelin receptor classification: time for reconsideration?](https://scholariq.org/papers/the-current-endothelin-receptor-classification-time-for-reconsideration/)
- [Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease](https://scholariq.org/papers/colchicine-attenuates-inflammation-beyond-the-inflammasome-in-chronic-coronary/)
- [Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE](https://scholariq.org/papers/cancer-associated-thrombosis-in-everyday-practice-perspectives-from-garfield-vte/)
- [The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics](https://scholariq.org/papers/the-effect-of-low-dose-colchicine-in-patients-with-stable-coronary-artery/)
- [PCSK9 Antibody Alirocumab Attenuates Arterial Wall Inflammation Without Changes in Circulating Inflammatory Markers](https://scholariq.org/papers/pcsk9-antibody-alirocumab-attenuates-arterial-wall-inflammation-without-changes/)
- [Kidney and Survival Benefits of Semaglutide in Diabetes With Chronic Kidney Disease](https://scholariq.org/papers/kidney-and-survival-benefits-of-semaglutide-in-diabetes-with-chronic-kidney/)

## Researcher topics

- [Nitric Oxide and Endothelin Effects](https://scholariq.org/topics/nitric-oxide-and-endothelin-effects/)
- [Inflammasome and immune disorders](https://scholariq.org/topics/inflammasome-and-immune-disorders/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Biomarkers in Disease Mechanisms](https://scholariq.org/topics/biomarkers-in-disease-mechanisms/)
- [Atherosclerosis and Cardiovascular Diseases](https://scholariq.org/topics/atherosclerosis-and-cardiovascular-diseases/)

## Researcher university

- [Çevre, Şehircilik ve İklim Değişikliği Bakanlığı](https://scholariq.org/institutions/cevre-sehircilik-ve-iklim-degisikligi-bakanl-g/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.